Measuring interferon alpha and other cytokines in SLE

Methods in Molecular Biology

Volumn 1134, Issue , 2014, Pages 131-150

  Olferiev, Mikhail ^a   Lliguicota, Mari ^a   Kirou, Kyriakos A ^a   Crow, Mary K ^a  

^a HOSPITAL FOR SPECIAL SURGERY   (United States)

Author keywords

Cytokines; Gene expression; Interferon alpha; Neutrophil granule signature; qPCR; Response; SLE; WISH

Indexed keywords

ALPHA INTERFERON; CYTOKINE; INTERFERON;

ARTICLE; BLOOD SAMPLING; CELLULAR IMMUNITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HELA CELL; HUMAN; HUMAN CELL; IMMUNOASSAY; IMMUNOLOGICAL PARAMETERS; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; SEROLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS; WISH ASSAY;

CELL LINE; CYTOKINES; GENE EXPRESSION REGULATION; HUMANS; INTERFERON-ALPHA; LEUKOCYTES, MONONUCLEAR; LUPUS ERYTHEMATOSUS, SYSTEMIC;

EID: 84896304039     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4939-0326-9_10     Document Type: Article

References (34)

1. Becker-Merok A, Østli-Eilersten G, Lester S et al (2013) Circulating interferon-?2 levels are increased in the majority of patients with systemic lupus erythematosus and are associated with disease activity and multiple cytokine activation. Lupus 22:155-163
2. Crow MK, Wohlgemuth J (2003) Microarray analysis of gene expression in lupus. Arthritis Res Ther 5:279-287
3. Bennett L, Palucka a K, Arce E et al (2003) Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med 197:711-723
4. Nzeusseu Toukap A, Galant C, Theate I et al (2007) Identification of distinct gene expression profiles in the synovium of patients with systemic lupus erythematosus. Arthritis Rheum 56:1579-1588
5. Crow MK (2010) Interferon-alpha: a therapeutic target in systemic lupus erythematosus. Rheum Dis Clin North Am 36:173-186
6. Lövgren T, Eloranta M-L, Båve U et al (2004) Induction of interferon-alpha production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG. Arthritis Rheum 50:1861-1872
7. Crow MK (2008) Collaboration, genetic associations, and lupus erythematosus. N Engl J Med 358:956-961
8. Wang C, Sandling JK, Hagberg N et al (2013) Genome-wide profiling of target genes for the systemic lupus erythematosus-associated transcription factors IRF5 and STAT4. Ann Rheum Dis 72:96-103
9. Connolly JJ, Hakonarson H (2012) Role of cytokines in systemic lupus erythematosus: recent progress from GWAS and sequencing. J Biomed Biotechnol 2012:1-17
10. Mikita N, Ikeda T, Ishiguro M et al (2011) Recent advances in cytokines in cutaneous and systemic lupus erythematosus. J Dermatol 38: 839-849
11. Poole BD, Niewold TB, Tsokos GC (2012) Cytokines in systemic lupus erythematosus 2011. J Biomed Biotechnol 2012:427824
12. Su D-L, Lu Z-M, Shen M-N et al (2012) Roles of pro- and anti-inflammatory cytokines in the pathogenesis of SLE. J Biomed Biotechnol 2012:347141
13. Bustin SA, Benes V, Garson JA et al (2009) The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 55(4):611-622
14. Overbergh L, Giulietti A, Valckx D et al (2003) The use of real-time reverse transcriptase PCR for the quantification of cytokine gene expression. J Biomol Tech 14:33-43
15. Boeuf P, Vigan-Womas I, Jublot D et al (2005) CyProQuant-PCR: a real time RT-PCR technique for profiling human cytokines, based on external RNA standards, readily automatable for clinical use. BMC Immunol 6:5
16. Brazma A, Hingamp P, Quackenbush J (2001) Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat Genet 29(4):365-371
17. Gentleman RC, Carey VJ, Bates DM et al (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5:R80
18. Huang DW, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4:44-57
19. Samarajiwa SA, Forster S, Auchettl K et al (2009) INTERFEROME: the database of interferon regulated genes. Nucleic Acids Res 37:D852-D857
20. Seo Y-J, Kim G-H, Kwak H-J et al (2009) Validation of a HeLa Mx2/Luc reporter cell line for the quantification of human type I interferons. Pharmacology 84:135-144
21. Bürgi M, Prieto C, Etcheverrigaray M et al (2012) WISH cell line: from the antiviral system to a novel reporter gene assay to test the potency of human IFN-and IFN-. J Immunol Methods 381:70-74
22. Hua J, Kirou K, Lee C et al (2006) Functional assay of type I interferon in systemic lupus erythematosus plasma and association with anti-RNA binding protein autoantibodies. Arthritis Rheum 54:1906-1916
23. Yousefi S, Escobar MR, Gouldin CW (1985) A practical cytopathic effect/dye-uptake interferon assay for routine use in the clinical laboratory. Am J Clin Pathol 83:735-740
24. Hayflick L (1961) The establishment of a line (WISH) of human amnion cells in continuous cultivation. Exp Cell Res 23:14-20
25. Nelson-Rees WA, Flandermeyer RR (1976) HeLa cultures defined. Science (New York, NY) 191:96-98
26. Chen TR (1988) Re-evaluation of HeLa, HeLa S3, and HEp-2 karyotypes. Cytogenet Cell Genet 48:19-24
27. Nalbandian A, Crispín JC, Tsokos GC (2009) Interleukin-17 and systemic lupus erythematosus: current concepts. Clin Exp Immunol 157:209-215
28. Novick D, Elbirt D, Miller G et al (2010) High circulating levels of free interleukin-18 in patients with active SLE in the presence of elevated levels of interleukin-18 binding protein. J Autoimmun 34:121-126
29. Okamoto H, Katsumata Y, Nishimura K et al (2004) Interferon-inducible protein 10/CXCL10 is increased in the cerebrospinal fluid of patients with central nervous system lupus. Arthritis Rheum 50: 3731-3732
30. Vega L, Barbado J, Almansa R et al (2010) Prolonged standard treatment for systemic lupus erythematosus fails to normalize the secretion of innate immunity-related chemokines. Eur Cytokine Netw 21:71-76
31. López P, Gómez J, Prado C et al (2008) Influence of functional interleukin 10/tumor necrosis factor-alpha polymorphisms on interferon-alpha, IL-10, and regulatory T cell population in patients with systemic lupus erythematosus receiving antimalarial treatment. J Rheumatol 35:1559-1566
32. Park YB, Lee SK, Kim DS et al (1998) Elevated interleukin-10 levels correlated with disease activity in systemic lupus erythematosus. Clin Exp Rheum 16:283-288
33. George-Chandy A, Trysberg E, Eriksson K (2008) Raised intrathecal levels of APRIL and BAFF in patients with systemic lupus erythematosus: relationship to neuropsychiatric symptoms. Arthritis Res Ther 10:R97
34. Sarra M, Monteleone G (2010) Interleukin-21: a new mediator of inflammation in systemic lupus erythematosus. J Biomed Biotechnol 2010:294582